B-SOFT(SZ:300451)2026-01-30 10:04Financial Performance - The company expects a net profit in the range of -405 million to -305 million CNY for the fiscal year 2025, compared to a net profit of -173.52 million CNY in the same period last year [4]. - The net profit after deducting non-recurring gains and losses is projected to be between -415 million and -315 million CNY, down from -192.06 million CNY year-on-year [4]. - The company faces increased losses due to a contraction in client investment in healthcare information technology, leading to a decline in operating revenue [6]. Product Development and Market Position - The new generation HI-HIS product has been deployed in over 100 hospitals across more than 20 provinces, but its short-term contribution to revenue is limited as it is still in the market introduction phase [7]. - The competitive landscape in the healthcare information technology sector has intensified, compressing profit margins due to aggressive pricing strategies from new entrants [8]. - The company has invested heavily in AI research and development, which has increased costs and further pressured profit margins amid declining revenues [8]. - An impairment test for goodwill is expected to result in a provision of approximately 100 million to 130 million CNY due to underperformance of certain subsidiaries [8]. Strategic Initiatives - The company is focusing on enhancing its core products and optimizing development processes to improve efficiency and quality [9]. - A partnership with Zhejiang University aims to establish a joint laboratory for AI in medicine, focusing on innovative applications and research [9]. - The company is implementing a comprehensive risk management system to address challenges in technology iteration, market competition, and talent retention [10].